BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10813539)

  • 1. Prevalence of MLR blocking antibodies before and after immunotherapy.
    Agrawal S; Pandey MK; Pandey A
    J Hematother Stem Cell Res; 2000 Apr; 9(2):257-62. PubMed ID: 10813539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion.
    Khonina NA; Broitman EV; Shevela EY; Pasman NM; Chernykh ER
    Arch Gynecol Obstet; 2013 Oct; 288(4):933-7. PubMed ID: 23558562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
    Pandey MK; Agrawal S
    Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Result of immunotherapy on patients with unexplained recurrent abortion: a beneficial treatment for patients with negative blocking antibodies.
    Takakuwa K; Goto S; Hasegawa I; Ueda H; Kanazawa K; Takeuchi S; Tanaka K
    Am J Reprod Immunol; 1990 Jun; 23(2):37-41. PubMed ID: 2145853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of immunotherapy for patients with unexplained secondary recurrent abortions.
    Adachi H; Takakuwa K; Mitsui T; Ishii K; Tamura M; Tanaka K
    Clin Immunol; 2003 Mar; 106(3):175-80. PubMed ID: 12706403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of LIT and MLR-Bf on Immune Biomarkers and Pregnancy Outcomes in Women With Previous Early Recurrent Miscarriage: A Retrospective Study.
    Meng L; Tan J; Du T; Lin X; Zhang S; Nie X; Xie H; Lin J; Zhang J; Hui C
    Front Immunol; 2021; 12():642120. PubMed ID: 34017330
    [No Abstract]   [Full Text] [Related]  

  • 7. Is an additional vaccination necessary for a successful second pregnancy in unexplained recurrent aborters who were successfully immunized with their husband's lymphocytes before the first pregnancy?
    Takakuwa K; Higashino M; Yasuda M; Ishii S; Ueda H; Asano K; Kazama Y; Tanaka K
    Am J Reprod Immunol; 1993 Jan; 29(1):39-44. PubMed ID: 8503994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of MLR-blocking factors after lymphocyte immunotherapy for RSA does not predict the outcome of pregnancy.
    Peña RB; Cadavid AP; Botero JH; García GP; Gallego MI; Ossa JE
    Am J Reprod Immunol; 1998 Feb; 39(2):120-4. PubMed ID: 9580175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on positive rate of blocking antibody in women with recurrent spontaneous abortion administered by route and frequency of paternal lymphocyte immunotherapy].
    Yu HL; Deng XH; Chao L; Chen C; Han YL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):903-6. PubMed ID: 24495682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological characteristics of nonpregnant women with unexplained recurrent spontaneous abortion who underwent paternal lymphocytes immunization.
    Malinowski A; Wilczynski J; Zeman K; Glowacka E; Kolasa D; Szpakowski A; Oszukowski P; Szpakowski M
    Zentralbl Gynakol; 1998; 120(10):493-502. PubMed ID: 9823650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of blocking antibodies by vaccination with husband's lymphocytes in unexplained recurrent aborters: the role in successful pregnancy.
    Takakuwa K; Kanazawa K; Takeuchi S
    Am J Reprod Immunol Microbiol; 1986 Jan; 10(1):1-9. PubMed ID: 2938488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of immunotherapy for patients with unexplained primary recurrent abortions--prospective non-randomized cohort study.
    Nonaka T; Takakuwa K; Ooki I; Akashi M; Yokoo T; Kikuchi A; Tanaka K
    Am J Reprod Immunol; 2007 Dec; 58(6):530-6. PubMed ID: 17997752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking antibodies in blood from patients with recurrent spontaneous abortion in relation to pregnancy outcome and intravenous immunoglobulin treatment.
    Jablonowska B; Palfi M; Ernerudh J; Kjellberg S; Selbing A
    Am J Reprod Immunol; 2001 Apr; 45(4):226-31. PubMed ID: 11327549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells.
    Yokoo T; Takakuwa K; Ooki I; Kikuchi A; Tamura M; Tanaka K
    Fertil Steril; 2006 May; 85(5):1452-8. PubMed ID: 16647376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition].
    Li D; Li C; Zhu Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):597-600. PubMed ID: 10806684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible mechanisms of immunotherapy for maintaining pregnancy in recurrent spontaneous aborters: analysis of anti-idiotypic antibodies directed against autologous T-cell receptors.
    Ito K; Tanaka T; Tsutsumi N; Obata F; Kashiwagi N
    Hum Reprod; 1999 Mar; 14(3):650-5. PubMed ID: 10221690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization.
    Beer AE; Semprini AE; Zhu XY; Quebbeman JF
    Exp Clin Immunogenet; 1985; 2(3):137-53. PubMed ID: 2978830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female third party lymphocytes are effective for immunotherapy of patients with unexplained primary recurrent spontaneous abortion: A retrospective analysis of outcomes.
    Liang X; Qiu T; Qiu L; Wang X; Zhao A; Lin Q
    Eur J Contracept Reprod Health Care; 2015; 20(6):428-37. PubMed ID: 25985825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA sharing, anti-paternal cytotoxic antibodies and MLR blocking factors in women with recurrent spontaneous abortion.
    Kishore R; Agarwal S; Halder A; Das V; Shukla BR; Agarwal SS
    J Obstet Gynaecol Res; 1996 Apr; 22(2):177-83. PubMed ID: 8697349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome.
    Smith JB; Cowchock FS
    J Reprod Immunol; 1988 Nov; 14(2):99-113. PubMed ID: 2976829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.